CH
STLN

CVI Holdings’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

CVI Holdings’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-200,000
Closed -$1.95M – 957
2021
Q4 		$1.95M Buy
+200,000
New +$1.78M 0.13% 263

Other funds holding STLN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
TM
Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

CVI Holdings's STLN Position: Q1 2022 in Review

CVI Holdings sold out of Starling Oncology Institute, Inc. Common Stock (STLN) in Q1 2022, closing a stake of 200,000 shares — an estimated $1.95M sold.

CVI Holdings first reported a position in STLN in Q4 2021 and held it in 1 quarter. The position peaked at $1.95M in Q4 2021. 29 funds tracked by Wall St. Rank hold STLN as of Q1 2022.

  • CVI Holdings reported no remaining Starling Oncology Institute, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • CVI Holdings sold 200,000 Starling Oncology Institute, Inc. Common Stock shares in Q1 2022, an estimated $1.95M.
  • CVI Holdings first reported a position in Starling Oncology Institute, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • CVI Holdings's Starling Oncology Institute, Inc. Common Stock position peaked at $1.95M in Q4 2021.
  • 29 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q1 2022.

Based on CVI Holdings's 13F filing for Q1 2022, filed 16 May 2022.